The world's largest exchange-traded fund, SPDR S&P 500 ETF Trust , saw outflows of $7.38B for the week ended July 3, while its price performance increased by 0.51% during the peri ...

In this week’s Computer Weekly, we announce the 16th annual UKtech50 list of the most influential people in UK technology. We examine how this year’s winner – Google DeepMind CEO Demis Hassabis – has ...

SPDR S&P 500 ETF Trust (SPY) had outflows of $29.62B, SPDR Gold Shares ETF (GLD) had inflows of $963.41M, and iShares Bitcoin Trust ETF (IBIT) had inflows of $109.73M during the past week.

Expansion of datacentre capacity – lately driven by demand for artificial intelligence (AI) processing – has sparked growing concern about the industry’s impact on water supplies. With datacentres set ...

ORIGIN 3 randomized 431 biopsy‑confirmed IgAN patients 1:1; atacicept 150 mg weekly SC produced the largest placebo‑adjusted UPCR reduction reported at week 36. Accelerated approval hinged on ...

Phase 4 DUET enrolled adults with NT1/NT2 or idiopathic hypersomnia (ESS >10) and showed ≥2-point ESS reductions in 82% of narcolepsy and 95% of hypersomnia participants. Normal-range ESS (≤10) was ...

This week Jonathan chats with Andy Gryc and Aaron Basset about QNX, and the interesting Open Source history and future of that embedded OS. Why does QNX Everywhere feel more open, and why do you need ...

Scouring through corporate communications and broker research isn’t enough Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years since that ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...